Antibiotic overuse and misuse have become a global concern, and India's antibiotic consumption patterns are a prime example of this growing issue. In this article, we'll delve into the findings of a recent study published in The Lancet Public Health, which sheds light on India's skewed antibiotic usage and its potential implications.
The Global Antibiotic Landscape
The study, conducted by an international team of researchers, analyzed antibiotic use across 186 countries, representing nearly the entire global population. The findings revealed a disturbing trend: nearly three-fourths of countries, including India, are using more antibiotics overall than necessary, while almost every country is overusing the antibiotics that contribute most to antimicrobial resistance.
What makes this particularly fascinating is the intricate classification system developed by the World Health Organization (WHO). Antibiotics are grouped into three categories: 'Access,' 'Watch,' and 'Reserve.' Each category serves a specific purpose, with 'Access' antibiotics being the first-choice for common infections, 'Watch' antibiotics reserved for specific, more complex infections, and 'Reserve' antibiotics acting as a last resort for multidrug-resistant infections.
India's Antibiotic Paradox
India's antibiotic usage, as estimated by the study, paints a picture of imbalance. The country ideally requires 14.7 defined daily doses (DID) of antibiotics per 1,000 people per day, with a breakdown of 7.8 DID for 'Access' antibiotics, 6 DID for 'Watch' antibiotics, and 0.99 DID for 'Reserve' antibiotics. However, the reality is quite different. India currently consumes 18.3 DID overall, with a disproportionate distribution: 4.5 DID for 'Access,' 9.3 DID for 'Watch,' and a mere 0.19 DID for 'Reserve' antibiotics.
This suggests that India is overusing 'Watch' antibiotics, potentially exposing patients to unnecessary risks, while underutilizing 'Reserve' antibiotics, which could lead to treatment gaps for multidrug-resistant infections. From my perspective, this is a critical issue that warrants immediate attention and action.
Global Implications and Challenges
The study's global perspective reveals a double-edged challenge. While some countries, including India, are overusing antibiotics, millions of people worldwide still lack access to the antibiotics they desperately need. This imbalance highlights the need for a nuanced approach to antibiotic stewardship, ensuring that the right antibiotics reach the right patients at the right time.
Furthermore, the study estimates that around 43 billion antibiotic treatment days were needed globally in 2019, indicating that one antibiotic course per person per year is sufficient for treating bacterial infections. This estimate aligns with the United Nations' target of 70% 'Access' antibiotic use by 2030, suggesting that a significant shift in antibiotic consumption patterns is necessary to achieve this goal.
India's Prescribing Patterns
The findings from India's National Centre for Disease Control's survey further emphasize the concerns raised by the Lancet study. Nearly three-fourths of hospitalized patients were found to be receiving antibiotics, with a majority of prescriptions falling into the 'Watch' category. Only a small percentage of prescriptions were based on microbiological evidence, indicating a potential lack of diagnostic precision.
Dr. Kamini Walia, an expert in antimicrobial resistance, highlights the issue of unnecessary duplicate antibiotic coverage and the extensive use of injectable antibiotics. She suggests that India should focus on reducing the unnecessary use of commonly prescribed 'Watch' antibiotics and restrict 'Reserve' antibiotics to patients with documented multidrug-resistant infections.
Conclusion
India's antibiotic consumption patterns, as revealed by this study, highlight the urgent need for improved antibiotic stewardship and awareness. The country's higher burden of infectious diseases and antimicrobial resistance necessitates a careful balance in antibiotic usage. By optimizing antibiotic prescriptions and ensuring access to the right antibiotics, India can contribute to the global effort in combating antimicrobial resistance and improving patient outcomes.
In my opinion, this study serves as a wake-up call, urging healthcare professionals, policymakers, and the public to take a closer look at their antibiotic usage habits and work towards a more sustainable and effective approach to antibiotic treatment.
